Inlyta 3 mg film-coated tablets

DRUG2 trials

Sponsors

Assistance Publique Hopitaux De Marseille, Rigshospitalet

Conditions

CancerEpendymomaMedulloblastoma

Phase 1

MEPENDAX: Phase I/II study of axitinib (Inlyta®) and oral metronomic etoposide for pediatric children and AYA with refractory/relapsing medulloblastoma and ependymoma

RecruitingCTIS2023-509585-38-00

Assistance Publique Hopitaux De MarseilleMedulloblastoma, Ependymoma

Start: 2024-11-19Target: 40Updated: 2025-11-07

Phase 2

ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling

RecruitingCTIS2023-510527-29-00

RigshospitaletCancer

Start: 2020-09-01Target: 600Updated: 2025-04-25